Clinical Trial Update: Stage I/II NSCLC Perioperative Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating perioperative chemotherapy for Stage I/II non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non-small Cell Lung Cancer Stage I and II, Peri-operative Chemotherapy | Phase 3 | Status: COMPLETED